| Fund ID | 805-2655123967 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 2% |
| Owned by funds of funds | 17% |
| Owned by non-U.S. persons | 22% |
| Fund | Type | Gross assets |
|---|---|---|
| Great Point Partners IV, L.P. | Private Equity | $547.9M |
| Great Point Partners III, LP | Private Equity | $271M |
| Biomedical Value Fund, L.P. | Hedge | $243.6M |
Gpp IV - Lyocontract, LLC reports $42.5 million in gross assets, among the top 57% of private funds by size.
The stated minimum investment is $50,000.
Gpp IV - Lyocontract, LLC is managed by Great Point Partners, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.